Aclarion broadens CLARITY trial enrollment criteria to speed recruitment, readout timing under review
ACON•Aclarion broadened enrollment criteria at its pivotal CLARITY trial to speed recruitment and keep the study on its original timeline. The revised criteria are in place at nine of 11 active sites; the company plans to update first-readout timing by year-end, reflecting stronger fourth-quarter enrollment.
1. Enrollment changes
Aclarion broadened enrollment criteria for its pivotal CLARITY trial to speed recruitment and keep the study on its original timeline. The revised criteria are in place at nine of 11 active sites, with the remaining sites screening under the new framework; the change is intended to better match real-world chronic low back pain patients while preserving trial rigor.
